MedPath
NMPA Approval

Vortioxetine Hydrobromide Tablets

国药准字H20249356

November 15, 2024

Drug Information

氢溴酸伏硫西汀片

片剂

5mg(以C₁₈H₂₂N₂S计)

化学药品

November 15, 2024

Company Information

Applicant Company

重庆市北碚区水土镇方正大道21号

Manufacturing Company

重庆市北碚区水土镇方正大道21号附2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氢溴酸伏硫西汀片 - NMPA 批准文号 | MedPath